The Drug Companies Avoiding Trump’s Tariffs — For Now

Generic medicines face no tariffs, though the Trump administration reserves the right to revisit that in the future. Some branded drugmakers face a reduced tariff rate, but that could change if they don’t reach a so-called most-favored nation drug price deal. The post The Drug Companies Avoiding Trump’s Tariffs — For Now appeared first on…

Read More

Why 131 Hospitals Are Suing HHS Over Alleged Underpayment

A group of 131 hospitals has sued HHS over a CMS policy they say improperly reduces Medicare disproportionate share hospital (DSH) payments. The lawsuit is the latest in a decade-long legal battle over how the agency counts patient days and calculates payments for safety net hospitals. The post Why 131 Hospitals Are Suing HHS Over…

Read More

How Medicaid Contractors Stand To Gain From Trump’s Policy

States are paying contractors such as Deloitte, Accenture, and Optum millions of dollars to help them comply with the One Big Beautiful Bill Act — a law that will strip safety-net health and food benefits from millions. State governments rely on such companies to design and operate computer systems that assess whether low-income people qualify…

Read More

Listen: What the Vaccine Schedule Whiplash Means for Your Kids

LISTEN: After a federal judge blocked the Trump administration’s efforts to pare down childhood vaccine recommendations, plenty of questions remain — like how annual vaccines for the flu will get approved. KFF Health News chief Washington correspondent Julie Rovner spoke with WAMU about how the decision is rippling through the public health system. Big swings…

Read More

Dyslexia Comes Back To Bite President Trump

By MIKE MAGEE This past week, Donald Trump decided to get into a war of words with a person with dyslexia. His target was the Governor of California, Gavin Newsom, who has struggled with the learning disability since the age of 5. The President’s action was premeditated and intended to take the potential Democratic 2028…

Read More